Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Wall Street Analysts Think Natural Gas Services (NGS) Could Surge 38.57%: Read This Before Placing a Bet
Wall Street Analysts Think Natural Gas Services (NGS) Could Surge 38.57%: Read This Before Placing a Bet

Shares of Natural Gas Services (NGS) have gained 12.3% over the past four weeks to close the last trading session at $26.16, but there could still be a solid upside left in the stock if short-term

Wall Street Analysts Predict a 39.94% Upside in The Pennant Group (PNTG): Here's  What You Should Know
Wall Street Analysts Predict a 39.94% Upside in The Pennant Group (PNTG): Here's What You Should Know

Shares of The Pennant Group, Inc. (PNTG) have gained 8.8% over the past four weeks to close the last trading session at $24.01, but there could still be a solid upside left in the stock if

Should You Buy CVB Financial (CVBF) After Golden Cross?
Should You Buy CVB Financial (CVBF) After Golden Cross?

After reaching an important support level, CVB Financial Corporation (CVBF) could be a good stock pick from a technical perspective. CVBF recently experienced a "golden cross" event, which saw its

Wall Street Analysts Think Deluxe (DLX) Could Surge 36.06%: Read This Before Placing a Bet
Wall Street Analysts Think Deluxe (DLX) Could Surge 36.06%: Read This Before Placing a Bet

Deluxe (DLX) closed the last trading session at $19.66, gaining 26.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

How Much Upside is Left in Q2 Holdings (QTWO)? Wall Street Analysts Think 29.72%
How Much Upside is Left in Q2 Holdings (QTWO)? Wall Street Analysts Think 29.72%

Q2 Holdings (QTWO) closed the last trading session at $78.73, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Beyond (BBBY) Now Trades Above Golden Cross: Time to Buy?
Beyond (BBBY) Now Trades Above Golden Cross: Time to Buy?

Beyond, Inc. (BBBY) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, BBBY's 50-day simple moving average broke out above its

Wall Street Analysts Believe Syndax (SNDX) Could Rally 112.8%: Here's is How to Trade
Wall Street Analysts Believe Syndax (SNDX) Could Rally 112.8%: Here's is How to Trade

Syndax Pharmaceuticals (SNDX) closed the last trading session at $16.33, gaining 63.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet
Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet

Passage Bio, Inc. (PASG) closed the last trading session at $7.13, gaining 24.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Does The Beachbody Company (BODI) Have the Potential to Rally 96.55% as Wall Street Analysts Expect?
Does The Beachbody Company (BODI) Have the Potential to Rally 96.55% as Wall Street Analysts Expect?

The Beachbody Company, Inc. (BODI) closed the last trading session at $5.51, gaining 40.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

After Golden Cross, Bar Harbor Bankshares (BHB)'s Technical Outlook is Bright
After Golden Cross, Bar Harbor Bankshares (BHB)'s Technical Outlook is Bright

Bar Harbor Bankshares, Inc. (BHB) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, BHB's 50-day simple moving average broke out

Does Nexxen International Ltd. Sponsored ADR (NEXN) Have the Potential to Rally 53.34% as Wall Street Analysts Expect?
Does Nexxen International Ltd. Sponsored ADR (NEXN) Have the Potential to Rally 53.34% as Wall Street Analysts Expect?

Shares of Nexxen International Ltd. Sponsored ADR (NEXN) have gained 0.1% over the past four weeks to close the last trading session at $10.03, but there could still be a solid upside left in the

Wall Street Analysts Believe TTM (TTMI) Could Rally 27.33%: Here's is How to Trade
Wall Street Analysts Believe TTM (TTMI) Could Rally 27.33%: Here's is How to Trade

Shares of TTM Technologies (TTMI) have gained 2.8% over the past four weeks to close the last trading session at $44.57, but there could still be a solid upside left in the stock if short-term price

Does Arcutis Biotherapeutics (ARQT) Have the Potential to Rally 45.81% as Wall Street Analysts Expect?
Does Arcutis Biotherapeutics (ARQT) Have the Potential to Rally 45.81% as Wall Street Analysts Expect?

Arcutis Biotherapeutics, Inc. (ARQT) closed the last trading session at $15.52, gaining 8.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy?
Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy?

After reaching an important support level, Y-mAbs Therapeutics, Inc. (YMAB) could be a good stock pick from a technical perspective. YMAB recently experienced a "golden cross" event, which saw its

Wall Street Analysts Predict a 35.8% Upside in Ranpak Holdings (PACK): Here's  What You Should Know
Wall Street Analysts Predict a 35.8% Upside in Ranpak Holdings (PACK): Here's What You Should Know

Ranpak Holdings Corp (PACK) closed the last trading session at $5.28, gaining 52.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Guardian Pharmacy Services (GRDN)'s Technical Outlook is Bright After Key Golden Cross
Guardian Pharmacy Services (GRDN)'s Technical Outlook is Bright After Key Golden Cross

Guardian Pharmacy Services, Inc. (GRDN) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, GRDN's 50-day simple moving average broke

Wall Street Analysts Believe DoubleDown Interactive (DDI) Could Rally 99.48%: Here's is How to Trade
Wall Street Analysts Believe DoubleDown Interactive (DDI) Could Rally 99.48%: Here's is How to Trade

Shares of DoubleDown Interactive Co., Ltd. Sponsored ADR (DDI) have gained 4.8% over the past four weeks to close the last trading session at $9.65, but there could still be a solid upside left in

Wall Street Analysts Predict a 130.63% Upside in Foghorn Therapeutics (FHTX): Here's  What You Should Know
Wall Street Analysts Predict a 130.63% Upside in Foghorn Therapeutics (FHTX): Here's What You Should Know

Foghorn Therapeutics Inc. (FHTX) closed the last trading session at $5.06, gaining 1.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Wall Street Analysts Predict a 41.36% Upside in CI&T (CINT): Here's  What You Should Know
Wall Street Analysts Predict a 41.36% Upside in CI&T (CINT): Here's What You Should Know

Shares of CI&T Inc. (CINT) have gained 2.3% over the past four weeks to close the last trading session at $5.44, but there could still be a solid upside left in the stock if short-term price targets

Should You Buy Arcturus Therapeutics (ARCT) After Golden Cross?
Should You Buy Arcturus Therapeutics (ARCT) After Golden Cross?

Arcturus Therapeutics Holdings Inc. (ARCT) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ARCT's 50-day simple moving

Wall Street Analysts Believe ARKO (ARKO) Could Rally 32.6%: Here's is How to Trade
Wall Street Analysts Believe ARKO (ARKO) Could Rally 32.6%: Here's is How to Trade

Shares of ARKO Corp. (ARKO) have gained 25.3% over the past four weeks to close the last trading session at $5, but there could still be a solid upside left in the stock if short-term price targets

S&T Bancorp (STBA)'s Technical Outlook is Bright After Key Golden Cross
S&T Bancorp (STBA)'s Technical Outlook is Bright After Key Golden Cross

After reaching an important support level, S&T Bancorp, Inc. (STBA) could be a good stock pick from a technical perspective. STBA recently experienced a "golden cross" event, which saw its 50-day

Here's Why Ascentage Pharma Group International - Unsponsored ADR (AAPG) Is a Great 'Buy the Bottom' Stock Now
Here's Why Ascentage Pharma Group International - Unsponsored ADR (AAPG) Is a Great 'Buy the Bottom' Stock Now

Shares of Ascentage Pharma Group International - Unsponsored ADR (AAPG) have been struggling lately and have lost 11.3% over the past week. However, a hammer chart pattern was formed in its last

Here's Why XOMA Royalty (XOMA) Is a Great 'Buy the Bottom' Stock Now
Here's Why XOMA Royalty (XOMA) Is a Great 'Buy the Bottom' Stock Now

Shares of XOMA Royalty (XOMA) have been struggling lately and have lost 5.1% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the

Wall Street Analysts Think Amneal (AMRX) Could Surge 25.52%: Read This Before Placing a Bet
Wall Street Analysts Think Amneal (AMRX) Could Surge 25.52%: Read This Before Placing a Bet

Shares of Amneal Pharmaceuticals (AMRX) have gained 22.1% over the past four weeks to close the last trading session at $9.56, but there could still be a solid upside left in the stock if short-term